Indeed, IL-6 plasma levels in COVID-19 severe patients are 10- to 40-fold lower than previously reported ARDS patients, and 1000-fold lower compared with patients facing cytokine release syndrome following treatment with chimeric antigen receptor T cells10,11. Here, IL6 is linked to COVID-19.